Amer Alghabban
Nessuna posizione attualmente
Profilo
Amer Alghabban worked as a Director at Merck KGaA, a Managing Director at Gxp Compliance & Training Partners, a Senior Audit Manager at Novartis AG, a Global Head-GxP Quality Assurance at Arpida AG, a VP-GxP, Quality Assurance, Compliance & Training at Karyopharm Therapeutics, Inc., and a Compliance Officer at Medicines & Healthcare Products Regulatory Agency.
Precedenti posizioni note di Amer Alghabban
Società | Posizione | Fine |
---|---|---|
Medicines & Healthcare Products Regulatory Agency | Responsabile della Conformità | - |
NOVARTIS AG | Comptroller/Controller/Auditor | - |
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Corporate Officer/Principal | - |
MERCK KGAA | Direttore/Membro del Consiglio | - |
Gxp Compliance &Training Partners | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
MERCK KGAA | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 3 |
---|---|
Gxp Compliance &Training Partners | |
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Medicines & Healthcare Products Regulatory Agency | Government |
- Borsa valori
- Insiders
- Amer Alghabban